Morningside Private Investors is a private equity general partner firm located in United States.
Elysium Health, a provider of dietary supplements, has raised $20m in Series B financing from General Catalyst and others.
Apellis Pharmaceuticals, a biotech company backed by Morningside Ventures, Epidarex and AJU IB Investment, withdrew its plans for an IPO.
French biotech Enyo Pharma has raised a €22m Series A funding round from Sofinnova Partners, Morningside Ventures and BPI France.
Read more news concerning Morningside Private Investors
A sampling of Morningside Private Investors portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?